Adamas Pharmaceuticals
Emeryville
About Adamas Pharmaceuticals
Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. The company was incorporated in 2000 and is headquartered in Emeryville, California with operations in India, the United States, and Singapore.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $483.2M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2021)
- Ticker: nasdaq:ADMS
- Website: adamaspharma.com
- Phone: 5104280519
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/adamas-pharmaceuticals-171282 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.